Translingual neurostimulation device
Total Trials
11
As Lead Sponsor
As Collaborator
0
Total Enrollment
519
NCT04496531
Efficacy of PoNS in Reducing Symptoms of Multiple Sclerosis
Phase: N/A
Role: Lead Sponsor
Start: Dec 31, 2014
Completion: Aug 31, 2016
NCT02429167
Study of Safety and Effectiveness of PoNS Device to Treat Chronic Balance Deficit Due to Traumatic Brain Injury (TBI)
Start: Aug 31, 2015
Completion: Aug 18, 2017
NCT03881202
PoNS Clinical Experience Program (TBI)
Start: Jun 30, 2018
Completion: Nov 30, 2019
NCT03882554
NCT03881176
PoNS Clinical Experience Program in Traumatic Brain Injury Patients (TBI)
Start: Sep 21, 2018
NCT03852732
Start: Feb 21, 2019
NCT03732755
Start: Apr 1, 2019
NCT05437276
A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)
Start: Jul 1, 2022
Completion: Dec 31, 2024
NCT06930339
Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis
Start: May 1, 2023
Completion: Apr 30, 2026
NCT06336720
PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study
Start: May 1, 2024
Completion: Sep 30, 2025
NCT06470009
Portable Neuromodulation Stimulator (PoNS®) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Randomized Controlled Trial.
Start: Jun 12, 2024
Loading map...